Hemostasis, platelet function and serotonin in acute and chronic renal failure.

@article{Mayszko1996HemostasisPF,
  title={Hemostasis, platelet function and serotonin in acute and chronic renal failure.},
  author={Jolanta Małyszko and Jolanta Małyszko and Dariusz Pawlak and Krystyna Pawlak and Włodzimierz Buczko and Michał Myśliwiec},
  journal={Thrombosis research},
  year={1996},
  volume={83 5},
  pages={
          351-61
        }
}
A pathogenetic role for fibrin deposition and platelet activation in the kidney is thought to play a role in the pathogenesis of acute renal failure (ARF). Thus, some fibrinolytic parameters and platelet function have been studied in 17 patients with ARF and compared to healthy volunteers and subjects with chronic renal failure (CRF). Since serotonin may participate in pathological processes resulting from platelet/vessel wall interactions, its level in the whole blood and plasma was also… Expand
The Role of Intrinsic Fibrinolytic System Activation in Pathogenesis of Hemostasis Disturbances in Hemodialized Patients with Chronic Renal Failure
TLDR
Increased plasmin production and fibrin digestion despite determination of decreased general fibrinolytic activity in patients treated with hemodialysis because of chronic renal failure caused by chronic glomerulonephritis is suggested. Expand
Platelet (Dys)function and Plasma Plasminogen Levels in Hemodialysis Patients
  • B. Salobir, M. Šabovič, I. Zupan, J. B. Ponikvar
  • Medicine
  • Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
  • 2008
TLDR
In hemodialysis patients platelet (dys)function appears to be associated with both the fibrinolytic and coagulation systems, and platelet aggregation significantly correlates with plasma plasminogen levels. Expand
Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance.
TLDR
Increased plasma levels of fibrinogen, D-dimer, and prothrombin fragment 1 + 2 are present in hypertensive patients with mildly decreased creatinine clearance, suggesting that the coagulation system is activated in these patients. Expand
Enhanced Expression of Plasminogen Activator Inhibitor 1 in Patients with Nephrotic Syndrome
TLDR
The results indicate that the fibrinolytic activity is increased in patients with nephrotic syndrome despite urinary losses of tPA, and a relatively enhanced expression of PAI-1 may be involved in the intraglomerular fibrinogen/fibrin-related antigen deposition seen in neph rotic syndrome. Expand
Hemostasis in chronic renal failure.
TLDR
In a variety of slowly progressive renal diseases such as chronic glomerulonephritis, diabetic nephropathy, and polycystic kidney disease, it is at present, not possible or very difficult to correct the underlying disease. Expand
Plasma Fibrinogen Level Is an Important Determinant of Prolonged Euglobulin Clot Lysis Time in Hemodialysis Patients
  • J. Borawski, M. Myśliwiec
  • Medicine
  • Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • 2001
TLDR
Increased plasma FBG level, a continuum between liver dysfunction and stimulation by chronic inflammation, is an important determinant of prolonged ECLT in HD patients and the FBG-corrected ECLt value suggests that baseline activation of fibrinolysis is normal in these patients, and this simple index could be useful in its laboratory assessment. Expand
Thrombin-Anti-Thrombin Levels and Patency of Arterio-Venous Fistula in Patients Undergoing Haemodialysis Compared to Healthy Volunteers: A Prospective Analysis
TLDR
In patients on haemodialysis, TAT levels were increased and inversely correlated with primary assisted patency and secondary patency, and further evaluation is required into the possible role of TAT as a biomarker of AVF occlusion. Expand
Effect of Erythropoietin on Activity of Plasma Proteolytic Systems during Experimental Renal Failure
Activity of plasma proteolytic systems (fibrin formation, fibrinolysis, and anticoagulant system) and the possibility for correction of changes in these systems with erythropoietin were studied inExpand
Comparison of Hemostatic Disturbances between Patients on Capd and Patients on Hemodialysis
TLDR
Patients on CAPD showed evidence of a higher degree of hypercoagulation than HD patients, suggesting hemostatic abnormalities in end-stage renal failure may be affected to some extent by the choice of renal replacement therapy. Expand
Coagulation, thrombophilia and patency of arteriovenous fistula in children undergoing haemodialysis compared with healthy volunteers: a prospective analysis
TLDR
The promising finding is that in children on haemodialysis, D-dimer levels were increased and inversely correlated with secondary patency, which could help to identify patients at an increased risk of arteriovenous fistula (AVF) occlusion. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 40 REFERENCES
A study of platelet functions, some hemostatic and fibrinolytic parameters in relation to serotonin in hemodialyzed patients under erythropoietin therapy.
TLDR
It is concluded that rHuEPO may improve platelet/vessel wall interactions possibly by means of serotonergic mechanisms and a lowered activity of inhibitors of fibrinolysis may be regarded as a protection against a general tendency to thrombosis during r HuEPO therapy. Expand
Selective Reduction of Serotonin Storage and ATP Release in Chronic Renal Failure Patient Platelets
TLDR
For the first time, there is a statistically significant correlation of ATP release and 5HT content to bleeding times (P < 0.001) and it is proposed that the reduced level of releasable platelet 5HT and ATP contributes to bleeding disorders commonly encountered in CRF patients. Expand
Glomerular coagulation system in renal diseases.
TLDR
Novel methods allowing the study of glomerular hemostatic activities in renal biopsy fragments should help to understand the mechanisms of fibrin deposition in human diseases and to treat it on a logical basis. Expand
Factors influencing platelet aggregation in whole blood.
TLDR
Collagen- and ADP-induced aggregation were significantly higher and lower, respectively, in whole blood than in PRP using the densitometric method and no differences were observed in SPA and collagen platelet aggregation according to age and sex. Expand
Platelet and plasma serotonin concentration in glomerulonephritis I.
TLDR
The assay of platelet serotonin is a valuable method of following in vivo platelet activation, based on the spectrofluorimetric estimation of the OPT conjugate of serotonin, and unaffected by conditions of taking or processing the blood. Expand
Plasma D dimer: a useful marker of fibrin breakdown in renal failure.
TLDR
Results indicate an increase in fibrin formation and lysis, and not simply reduced elimination of D dimer by the kidneys, and are further evidence of activated coagulation in renal disease. Expand
Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis.
TLDR
It is concluded that the platelet dysfunction in uremia is multifaceted, and there appears to be an aggregation and secretion defect related to impaired arachidonic acid release from platelet phospholipids as well as a storage pool defect. Expand
Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes.
TLDR
5-HT-induced platelet aggregation was found to be significantly higher throughout the study in DM patients over controls in parallel to plasma 5-HT, which may contribute, at least partly, to the pathogenesis of diabetic vasculopathy and 5HT2 receptor blockers. Expand
Platelets and platelet function in patients with chronic uremia on maintenance hemodialysis.
TLDR
It is concluded that on well-controlled hemodialysis treatment, bleeding tendency should not be a major problem and many cases of so-called uremic bleeding are caused by the medication taken. Expand
Fibrinolytic activators and inhibitors in terminal renal insufficiency and in anephric patients.
Fibrinolytic factors were measured before and after DDAVP-infusion in 18 patients on chronic, regular haemodialysis, 11 of whom underwent bilateral nephrectomy, and in 7 patients in whomExpand
...
1
2
3
4
...